Sarah Weske

Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content

Katherine Sattler, Markus H. Gräler, Petra Keul et al. · Journal of the American College of Cardiology · 2015 · 122 citations

Low Sphingosine-1-phosphate Content, Lipid Disorder, Vascular Disease +11

Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss

Sarah Weske, Mithila Vaidya, A. Reese et al. · Nature Medicine · 2018 · 112 citations

Bone Disease, Bone Loss, Sclerostin +7

Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages

Mithila Vaidya, Julian A. Jentsch, Susann Peters et al. · Journal of Lipid Research · 2019 · 52 citations · Full text

Agonist-induced activation of the S1P receptor 2 constitutes a novel osteoanabolic therapy for the treatment of osteoporosis in mice

Sarah Weske, Mithila Vaidya, Karin von Wnuck Lipinski et al. · Bone · 2019 · 27 citations

Agonist-induced Activation, S1p Receptor 2, Sclerostin +10

Hepatocyte Nuclear Factor 1A Is a Cell-Intrinsic Transcription Factor Required for B Cell Differentiation and Development in Mice

Karin von Wnuck Lipinski, Katherine Sattler, Susann Peters et al. · The Journal of Immunology · 2016 · 15 citations · Full text